Form 4 for ABT Abbott Laboratories
Accepted 2024-09-04 00:00:00 ET · period of report 2024-09-01 · accession 0001415889-24-022823 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-04 | 2024-09-01 | ABT | Boudreau Philip P | EVP | F - Tax | $113.27 | -387 | 39.0K | -1.0% | -$43.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2024-09-01 | F | D | 387 | $113.27 | 38,966 | D | — | — |